Cargando…

Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery

Detalles Bibliográficos
Autores principales: Wangge, Grace, Klungel, Olaf H, Roes, Kit CB, de Boer, Antonius, Hoes, Arno W, Knol, Mirjam J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287747/
http://dx.doi.org/10.1186/1745-6215-12-S1-A32
_version_ 1782224734389272576
author Wangge, Grace
Klungel, Olaf H
Roes, Kit CB
de Boer, Antonius
Hoes, Arno W
Knol, Mirjam J
author_facet Wangge, Grace
Klungel, Olaf H
Roes, Kit CB
de Boer, Antonius
Hoes, Arno W
Knol, Mirjam J
author_sort Wangge, Grace
collection PubMed
description
format Online
Article
Text
id pubmed-3287747
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32877472012-02-28 Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery Wangge, Grace Klungel, Olaf H Roes, Kit CB de Boer, Antonius Hoes, Arno W Knol, Mirjam J Trials Oral Presentation BioMed Central 2011-12-13 /pmc/articles/PMC3287747/ http://dx.doi.org/10.1186/1745-6215-12-S1-A32 Text en Copyright ©2011 Wangge et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Wangge, Grace
Klungel, Olaf H
Roes, Kit CB
de Boer, Antonius
Hoes, Arno W
Knol, Mirjam J
Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery
title Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery
title_full Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery
title_fullStr Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery
title_full_unstemmed Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery
title_short Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery
title_sort challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287747/
http://dx.doi.org/10.1186/1745-6215-12-S1-A32
work_keys_str_mv AT wanggegrace challengesofdefininganoninferioritymarginacasestudyofnoninferiorityrandomizedcontrolledtrialsoforalantithrombolyticagentsforprophylaxisofvenousthromboemboliceventsafterorthopedicsurgery
AT klungelolafh challengesofdefininganoninferioritymarginacasestudyofnoninferiorityrandomizedcontrolledtrialsoforalantithrombolyticagentsforprophylaxisofvenousthromboemboliceventsafterorthopedicsurgery
AT roeskitcb challengesofdefininganoninferioritymarginacasestudyofnoninferiorityrandomizedcontrolledtrialsoforalantithrombolyticagentsforprophylaxisofvenousthromboemboliceventsafterorthopedicsurgery
AT deboerantonius challengesofdefininganoninferioritymarginacasestudyofnoninferiorityrandomizedcontrolledtrialsoforalantithrombolyticagentsforprophylaxisofvenousthromboemboliceventsafterorthopedicsurgery
AT hoesarnow challengesofdefininganoninferioritymarginacasestudyofnoninferiorityrandomizedcontrolledtrialsoforalantithrombolyticagentsforprophylaxisofvenousthromboemboliceventsafterorthopedicsurgery
AT knolmirjamj challengesofdefininganoninferioritymarginacasestudyofnoninferiorityrandomizedcontrolledtrialsoforalantithrombolyticagentsforprophylaxisofvenousthromboemboliceventsafterorthopedicsurgery